A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology
出版年份 2020 全文链接
标题
A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology
作者
关键词
-
出版物
Cells
Volume 9, Issue 9, Pages 2014
出版商
MDPI AG
发表日期
2020-09-02
DOI
10.3390/cells9092014
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pathogenesis of and major animal models used for nonalcoholic fatty liver disease
- (2019) Mingzuo Jiang et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis – Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue
- (2019) Samuel J. Daniels et al. BIOMEDICINE & PHARMACOTHERAPY
- Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications
- (2019) Michele Longo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients
- (2019) Naomichi Abe et al. Biology Open
- Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-/-.Leiden mice
- (2019) Kanita Salic et al. PLoS One
- Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease
- (2019) Jin Lee et al. ARCHIVES OF PHARMACAL RESEARCH
- Combined Treatment with L-Carnitine and Nicotinamide Riboside Improves Hepatic Metabolism and Attenuates Obesity and Liver Steatosis
- (2019) Kanita Salic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sex-Specific Differences in Fat Storage, Development of Non-Alcoholic Fatty Liver Disease and Brain Structure in Juvenile HFD-Induced Obese Ldlr-/-.Leiden Mice
- (2019) Sophie A.H. Jacobs et al. Nutrients
- Mitochondrial Dysfunction in the Transition from NASH to HCC
- (2019) Mélissa Léveillé et al. Metabolites
- Translating scientific discovery: the need for preclinical models of nonalcoholic steatohepatitis
- (2018) Abdul M. Oseini et al. Hepatology International
- FXR activation by obeticholic acid or nonsteroidal agonists induces a human-like lipoprotein cholesterol change in mice with humanized chimeric liver
- (2018) Romeo Papazyan et al. JOURNAL OF LIPID RESEARCH
- Extra-Virgin Olive Oil with Natural Phenolic Content Exerts an Anti-Inflammatory Effect in Adipose Tissue and Attenuates the Severity of Atherosclerotic Lesions in Ldlr −/−.Leiden Mice
- (2018) Amparo Luque-Sierra et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis
- (2018) Kirstine S Tølbøl et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Key Inflammatory Processes in Human NASH Are Reflected in Ldlr−/−.Leiden Mice: A Translational Gene Profiling Study
- (2018) Martine C. Morrison et al. Frontiers in Physiology
- Diet-Independent Correlations between Bacteria and Dysfunction of Gut, Adipose Tissue, and Liver: A Comprehensive Microbiota Analysis in Feces and Mucosa of the Ileum and Colon in Obese Mice with NAFLD
- (2018) Eveline Gart et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Butyrate restores HFD-induced adaptations in brain function and metabolism in mid-adult obese mice
- (2017) I A C Arnoldussen et al. INTERNATIONAL JOURNAL OF OBESITY
- Liver inflammation and fibrosis
- (2017) Yukinori Koyama et al. JOURNAL OF CLINICAL INVESTIGATION
- Butyrate Reduces HFD-Induced Adipocyte Hypertrophy and Metabolic Risk Factors in Obese LDLr-/-.Leiden Mice
- (2017) Charlotte Pelgrim et al. Nutrients
- The CCR2 Inhibitor Propagermanium Attenuates Diet-Induced Insulin Resistance, Adipose Tissue Inflammation and Non-Alcoholic Steatohepatitis
- (2017) Petra Mulder et al. PLoS One
- A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice
- (2017) Marieke H. Schoemaker et al. PLoS One
- Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients
- (2016) Andreas Teufel et al. GASTROENTEROLOGY
- Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR−/−.Leiden mice
- (2016) M C Morrison et al. INTERNATIONAL JOURNAL OF OBESITY
- Obeticholic acid improves adipose morphometry and inflammation and reduces steatosis in dietary but not metabolic obesity in mice
- (2016) Fahrettin Haczeyni et al. Obesity
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- Surgical removal of inflamed epididymal white adipose tissue attenuates the development of non-alcoholic steatohepatitis in obesity
- (2015) P Mulder et al. INTERNATIONAL JOURNAL OF OBESITY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone
- (2014) Lars Verschuren et al. BMC Medical Genomics
- Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin
- (2014) S. Kuhnast et al. EUROPEAN HEART JOURNAL
- Establishment of a General NAFLD Scoring System for Rodent Models and Comparison to Human Liver Pathology
- (2014) Wen Liang et al. PLoS One
- DNA Methylation Analysis in Nonalcoholic Fatty Liver Disease Suggests Distinct Disease-Specific and Remodeling Signatures after Bariatric Surgery
- (2013) Markus Ahrens et al. Cell Metabolism
- Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease
- (2013) Cynthia A. Moylan et al. HEPATOLOGY
- Strain dependence of diet-induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype
- (2013) Geoffrey C. Farrell et al. LIVER INTERNATIONAL
- Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
- (2010) Dina G. Tiniakos et al. Annual Review of Pathology-Mechanisms of Disease
- Animal models of nonalcoholic fatty liver disease
- (2010) Lionel Hebbard et al. Nature Reviews Gastroenterology & Hepatology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now